|
|
||||||||
J Biol Chem, Vol. 275, Issue 11, 7684-7692, March 17, 2000
From the Accumulating evidence suggests that
neuroepithelial bodies are airway O2 sensors.
Recently, we have established the H-146 small cell lung carcinoma line
as a suitable model to study the biochemical basis of neuroepithelial
body cell chemotransduction. Here we explore the possibility that
hypoxic modulation of K+ channels is intimately linked to
activity of NADPH oxidase. Graded hypoxia caused graded inhibition of
whole cell K+ currents, which correlated well with membrane
depolarization. Pretreatment with the phorbol ester,
12-O-tetradecanoyl (TPA), inhibited K+ currents
at all potentials. Although 4 Ventilation-perfusion matching is essential for efficient
oxygenation of pulmonary blood in the face of varying demands of the
body's tissues. Numerous physiological processes have long been known
to ensure optimization of ventilation-perfusion matching, but the
cellular mechanisms underlying such processes are only now
beginning to be understood. One such important mechanism is that of
O2 chemoreception, i.e. an active cellular
response to an acute general and/or regional reduction of
pO2. Most studies to date have focused on the
carotid body arterial chemoreceptors. Type I cells of these sensors
express O2-sensitive K+ channels, and exposure
to hypoxia causes rapid channel inhibition. This leads to cell
depolarization, Ca2+ entry via voltage-gated
Ca2+ channels, and subsequent triggering of neurosecretion,
an essential step in the initiation of afferent information, which
leads to reflex increases of ventilation (1, 2). In vascular smooth muscle, O2-sensitive K+ channels (3) and
Ca2+ channels (4) have more recently been reported, and
their rapid modulation by hypoxia evokes appropriate
vasodilatation or vasoconstriction (depending on the location of the
blood vessel (5)).
Compelling evidence is emerging that neuroepithelial bodies
(NEBs),1 located in clusters
at bronchial bifurcations throughout the lung, serve as airway
chemoreceptors (6, 7). Like their vascular counterparts in the carotid
body, NEB cells possess numerous transmitters, which appear to be
released in hypoxia (8). These transmitters (particularly serotonin)
may act to initiate afferent nerve activity to medullary respiratory
centers and may also act to control local vasomotor tone, hence
directly influencing local ventilation-perfusion matching (9). Compared
with type I cells of the carotid body, our understanding of
O2 chemoreception by NEB cells is in its infancy, due
largely to the technically demanding nature of their isolation/primary
culture or to the difficulty in recording currents in situ
using the lung slice. However, it has been established that they are
electrically excitable and, most importantly, possess
O2-sensitive K+ channels (7, 10), suggesting
that they may respond, at least superficially, like carotid body type I
cells. In recent studies, we have built on the suggestions of others to
establish that small cell lung carcinoma (SCLC) cells, which are
believed to be derived from NEB cells (11) and with which they share
numerous similarities (12), represent immortal airway chemoreceptors.
Thus, we have recently identified, in the SCLC cell line H-146, a
specific component of the whole cell K+ current, which is
sensitive to hypoxia and influences membrane potential (13, 14). This
current is 4-aminopyridine- (4-AP) and Ca2+-insensitive,
quinidine-sensitive, and may be a novel member of the tandem P-domain
family of K+ channels. The ease of use of cell lines as
compared with isolated NEB cells or lung slices suggests that they may
be exploited to understand the molecular and biochemical mechanisms
underlying rapid effects of hypoxia on chemoreceptor cells.
The mechanism(s) which couple a fall of pO2 to
K+ channel inhibition remain elusive, but recent work has
implicated the involvement of NADPH oxidase as an O2 sensor
in both NEB cells and SCLC cells (15). The NADPH oxidase model for
O2 chemoreception suggests that, under normoxic conditions,
the oxidase tonically generates superoxide from O2, which
is rapidly converted to H2O2 by a number of
enzymes including superoxide dismutase and catalase. This
H2O2 is believed to promote channel activity.
It follows, therefore, that H2O2 levels will
decline in hypoxia, causing a concomitant reduction in channel
activity. Several independent lines of evidence support this idea: (i)
NEB and SCLC cells express the mRNA encoding K+
channels known to be modulated by H2O2; (ii)
in situ hybridization and immunohistochemistry have
indicated that specific subunits of NADPH oxidase (gp91phox
and p22phox) are present in both cell types; (iii)
H2O2 generation in NEB cell clusters is
significantly greater than in surrounding tissue, can be enhanced by
protein kinase C (PKC) activation using phorbol ester (which
specifically phosphorylates another subunit, p47phox, of
the oxidase complex), and can be suppressed by diphenyleneiodonium, a
known NADPH oxidase inhibitor and; iv), K+ currents can be
enhanced (albeit transiently) by application of
H2O2 (10, 15). Collectively, these observations
support the idea that hypoxic inhibition of K+ channels in
airway chemoreceptor cells and SCLC cells involves reduced levels of
H2O2 derived from NADPH oxidase activity, but a
direct link between the observations is still lacking. Indeed, it has,
to date, never been demonstrated directly that hypoxia causes a fall of
H2O2 levels in these cells.
In the present study, we demonstrate for the first time that
H2O2 production declines during hypoxia and
have exploited the fact that NADPH oxidase activity can be regulated by
PKC-dependent phosphorylation (16) to test further this
model for O2 chemoreception in SCLC cells. Our results
provide compelling functional evidence to support a central role
for NADPH oxidase in this important process, and we propose that PKC
may modulate chemoreception by altering the affinity of the oxidase for
O2.
Cell Culture
The small cell lung carcinoma cell line, H-146, was purchased
from American Tissue Type Cell Collection (Rockville, MD) and was of
unknown passage number. Cells were grown in suspension culture in RPMI
1640 medium (containing L-glutamine) supplemented with 10%
fetal calf serum, 2% sodium pyruvate, and 2% penicillin/streptomycin (all from Life Technologies, Inc.) in a humidified atmosphere of 5%
CO2/95% air at 37 °C. Medium was changed every 2 days
and cells were passaged every 6-7 days by splitting in the ratio 1:5. Cells were used between nominal passage numbers 1 and 6.
Electrophysiology
Solutions and Chemicals--
Unless stated otherwise, all
chemicals were of the highest grade available and were purchased from
Sigma. Standard pipette solution was K+-rich and contained:
10 mM NaCl, 117 mM KCl, 2 mM
MgSO4, 10 mM HEPES, 11 mM EGTA, 1 mM CaCl2, 2 mM Na2ATP,
pH 7.2, with KOH; free [Ca2+] = 27 nM.
Standard bath solution was Na+-rich and contained: 135 mM NaCl, 5 mM KCl, 1.2 mM
MgCl2, 5 mM HEPES, 2.5 mM
CaCl2, 10 mM D-glucose, pH 7.4, with NaOH. 4-AP was added to the bath solution where indicated, and osmolarity was
maintained by isoosmotic substitution of NaCl. Where indicated, cells
were preincubated with 100 nM of the phorbol esters
12-O-tetradecanoylphorbol-13-acetate (TPA) and 4
All tubing was gas-impermeant (Tygon tubing BDH, Atherstone, Berkshire,
UK). Normoxic solutions were equilibrated with room air. Solutions were
made hypoxic, where appropriate, by bubbling with N2(g) for
at least 30 min prior to perfusion of cells. This procedure produced no
shift in pH. Solution flow rate was ~5 ml·min Whole Cell Recording--
Following trituration (10 passes
through a 1-ml automatic pipette tip), cells were allowed to adhere at
37 °C for at least 1 h to poly-L-lysine-coated
glass coverslips before being placed in a temperature-controlled
perfusion chamber (Brook Industries, Lake Villa, IL) mounted on the
stage of a Nikon TMS inverted microscope. All experiments were carried
out at 21 ± 1 °C. Patch pipettes were manufactured from
standard walled borosilicate glass capillary tubing on a two-stage
Narishige PP-83 pipette puller (Narishige Scientific Instrument Lab,
Kasuya, Tokyo, Japan), were heat-polished on a Narishige microforge,
and had measured tip resistances of 3-8 M
Resistive feedback voltage-clamp was achieved using an Axopatch 200A
amplifier (Axon Instruments, Forster City, CA). Voltage protocols were
generated, and currents were recorded using pClamp 6.0.3 software
employing a Digidata 1200 A/D converter (Axon Instruments). Data were
filtered (4-pole Bessel) at 2 kHz and digitized at 5 kHz. Following
successful transition to the whole-cell recording mode (12),
capacitance transients were compensated for and measured. Where
necessary, series resistance compensation was used at 100%.
To evoke ionic currents in H-146 cells, two voltage protocols were
used: (a) ramp protocol: holding potential =
Fast current clamp was achieved using the same amplifier, and the
solutions were the same as those used in the voltage-clamp experiments.
Cells were clamped at I = 0 pA and the recorded voltage was
filtered at 1 kHz and digitized at 2 kHz.
Single Cell Fluorescence
H-146 cells were loaded for 30 min at 37 °C with 10 µM (in 0.01% dimethyl sulfoxide)
H2O2 fluorescent indicator
2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA,
Molecular Probes, Leiden, Netherlands) during adherence to
poly-L-lysine-coated coverslips (17). Coverslips were
mounted on the stage of Nikon Diaphot 300 and perfused with the
standard normoxic (150 mm Hg) bath solution (see above for composition). H2DCFDA was excited with light of wavelength
488 nm using a monochromator and emitted fluorescence (>510 nm)
collected by a CCD camera (Hamamatsu, C4880-80). Cells were imaged
using Openlab software at 2-s intervals, and pixel intensity was
calculated off-line. Following a control period of 20 s, cells
were perfused with standard bath solution for 2 min, which was either
air-equilibrated (150 mm Hg) or hypoxic (15 mm Hg). Recovery was
followed for a further 3 min.
Data Handling and Calculations
Electrophysiology--
The magnitude of the steady-state outward
currents (time-series protocol) was measured as the mean current
between 46 and 49 ms of the voltage-pulse. In the time-series plots,
the currents from each separate experiment were normalized by dividing
the current at each point by the mean of the first five currents in that series; in the figures, the numbers represent the mean (± S.E.);
n refers to the number of cells. Current amplitudes were not
corrected for cell size, because this did not vary between the four
groups of cells studied, as determined by membrane capacitance measurements; control cells, 5.0 ± 0.13 picoFarad
(n = 93); TPA-treated cells, 4.8 ± 0.23 picoFarad
(n = 57); 4 Fluorescence--
H2DCFDA is effectively trapped
within cells and, in common with most other flourescence indicators,
undergoes photobleaching. Because it is not a dual excitation or
emission dye, this artifact cannot be removed by signal ratioing. Thus,
during the experimental period, fluorescence intensity declines
exponentially with time. Nevertheless, a change in the rate of decay is
indicative of a change in cellular H2O2
content/production. Mean pixel intensity was calculated from each cell
area at intervals of 2 s, background fluorescence was subtracted,
and the subtracted intensity was plotted against time. The rate of
change of fluorescence was calculated as a rolling average of slope of
five consecutive frames for the entire duration of the experiment. To
account for any differential dye loading, slope data from each cell
were normalized such that the first average from each protocol was
unity. In Fig. 2, the mean data plot shows this rolling average
versus time. A downward deflection (indicative of an
increase in normalized slope value) represents a decrease in
H2O2 production/content. Exemplar, nonadjusted data are shown in the insets of Fig. 2.
RT-PCR--
Total RNA was extracted from pelleted H-146 cells
using the RNeasy Micro Kit (Qiagen, Crawley, W. Sussex, UK). The
extracted RNA was then divided; 50% was treated (cleaned) with RQ-1
RNase-free DNase (1 unit·µg Response to Graded Hypoxia--
In H-146 cells, we have recently
shown that acute hypoxia (pO2 ~15 mm Hg)
causes rapid and reversible inhibition of whole cell K+
currents and membrane depolarization (13). Fig.
1 extends our earlier observations to
show that reducing perfusate pO2 in a graded
manner (between 150 and 15 mm Hg) results in correspondingly graded
inhibition of these K+ currents and also causes graded
membrane depolarization (Fig. 1A). In this series of
experiments, a pO2 of 15 mm Hg significantly reduced mean outward K+ current amplitudes (measured at 0 mV) from 223.2 ± 28.9 pA to 149.6 ± 41.2 pA
(p < 0.005, n = 7), a reduction of
~33%. The same degree of hypoxia caused a significant
depolarization from -47.9 ± 1.3 mV to Effects of Hypoxia on H2O2 Production in
H-146 Cells--
Central to the hypothesis that NADPH oxidase acts as
the O2 sensor in airway chemoreceptors is the notion that
H2O2 levels are decreased during hypoxia. Fig.
2 demonstrates that this is indeed the
case in H-146 cells. During normoxia, fluorescence intensity gradually
declined because of photobleaching (Fig. 2A and
inset). However, perfusion with the hypoxic solution (15 mm Hg) caused a far greater decline in fluorescence intensity, approaching twice the base-line bleaching rate (observed under normoxic conditions (Fig. 2B and inset)). This effect was maximal
around 30 s after exchange to the hypoxic solution and was
reversible on reperfusion with normoxic solution. The time-course of
this effect was similar to that of hypoxic inhibition of K+
currents (see Ref. 13 and also Figs. 5 and 6). These data show clearly
that H2O2 levels in H-146 cells are regulated
by environmental pO2 and suggest that
K+ channels are under tonic control by a
H2O2-generating system.
Effects of Phorbol Esters on H-146 K+
Currents--
Preincubation of H-146 cells for 10 min with the
membrane-permeable PKC activator, TPA (100 nM), caused a
significant (p < 0.05, n = 11 control
cells and 8 TPA-treated cells; unpaired Student's t test)
reduction in ramp currents at all potentials (Figs.
3, A and B). To
determine the contribution which PKC activation made to this reduction
in current, we employed: (a) a biologically inactive phorbol
ester, 4 Effects of PKC Activation on Hypoxic Inhibition of K+
Currents in H-146 Cells--
Fig.
4A shows currents evoked by
ramp depolarizations from a typical H-146 cell before, during, and
after exposure to two levels of acute hypoxia. These currents exemplify
the reversible, graded inhibition caused by hypoxia, which is
summarized in Fig. 1A. In contrast to these findings,
currents recorded in cells pretreated with 100 nM TPA,
although reduced in amplitude (see above), were virtually unaffected by
hypoxia (e.g. Fig. 4B). Average current
amplitudes (measured at 0 mV) at all levels of hypoxia examined are
plotted in Fig. 4C. Thus, TPA markedly and
significantly (p < 0.01, n = 6 control cells; n = 4 TPA-treated cells) suppressed hypoxic inhibition of K+ currents in H-146 cells. The
results shown in Fig. 4D (determined from currents recorded
at 0 mV during normoxia and hypoxia at 15 mm Hg) indicate that this was
attributable to PKC activation, because neither 4
We have previously shown that the O2-sensitive
K+ current is resistant to 4-AP (14). Following treatment
with TPA, the proportion of the whole cell current, which was
4-AP-insensitive, remained essentially unchanged compared with control
(Fig. 5, A and D). However, in the presence of a maximally effective concentration of 4-AP
(10 mM), hypoxia (15 mm Hg) caused over 50% inhibition of
the residual current (e.g. Fig. 5, A,
C, and D). In contrast, hypoxic inhibition of the
4-AP-resistant current was significantly (p < 0.005, n = 8) reduced to around 25% following TPA treatment (e.g. Fig. 5, B, C, and E).
Fig. 5C shows the mean time course of these effects. This
observation shows that although TPA caused a generalized reduction in
current (see also Fig. 3), the 4-AP-resistant component was less
O2-sensitive in these cells when PKC was activated.
Although there are many PKC-dependent mechanisms that could
account for these data, one potential site of action for PKC might be
the NADPH-oxidase complex, which has been recently implicated in NEB
cell O2 sensing (15). If this is the case in our NEB cell
model, we would predict that products downstream of NADPH oxidase
activity would regulate the O2-sensitive K+
channel. We addressed this possibility by applying one such product, H2O2, in the presence of 4-AP. Fig.
6A shows that under normoxic conditions, H2O2 was without effect. However,
during hypoxic inhibition of the K+ current,
H2O2 caused a dramatic and transient
reactivation of the current. The time course of this effect was similar
to that previously reported in NEB cells (15).
A probable site of PKC-dependent phosphorylation of the
heteromeric enzyme, NADPH oxidase, is p47phox (16).
However, although there is good evidence for the presence in both
native NEB cells and H-146 cells of some of the components of the
enzyme (15), evidence for the presence of p47phox in H-146
cells is still lacking. Fig. 7 shows the
use of RT-PCR to address this question directly. Amplification of a
product compatible with the presence of p47phox (130 base
pairs) in genomic DNA (uncleaned lanes) shows that the PCR protocol
that we employed can detect p47phox (Fig. 7A).
Using this protocol, we could detect only a small signal from cDNA
reverse transcribed from DNase-treated H-146 RNA (cleaned lanes).
However, a turbo PCR reaction produced a strong signal (130 base pairs)
from the cleaned sample (Fig. 7A), indicating that
p47phox was indeed being transcribed by these cells
(confirmed by sequencing, Fig. 7B) but that its expression
was low because of either rapid degradation or low copy number of
p47phox mRNA; PCR cannot distinguish between these two
possibilities. Regardless, p47phox is present and is,
therefore, a possible site of PKC-dependent regulation of
the oxidase in our model airway chemoreceptor cells.
Electrophysiological studies have demonstrated that acute
reductions in pO2 suppress K+
currents in airway chemoreceptor NEBs (7) in a manner comparable to
their vascular counterparts, the type I cells of the carotid body (1,
19). Such an effect underlies membrane depolarization, which presumably
leads to activation of voltage-gated Ca2+ channels, thereby
permitting Ca2+ influx to trigger neurotransmitter release
in both cell types (8, 20). Previous studies, including our own, have
demonstrated that SCLC cell lines (such as H-146 used here), which are
derived from the same precursor pool as NEBs (11), provide an excellent model for studying mechanisms underlying hypoxic inhibition of NEB cell
K+ channel inhibition (13, 14). This is an important
advance given the present limitations of acutely isolated, primary
cultured NEB cells.
An important aim of the present study was to use PKC activation as a
method by which to investigate the transduction pathway responsible for
hypoxic suppression of K+ currents in our recently
established model of NEB O2 sensing. In NEB cells, it has
been proposed, but not directly substantiated, that NADPH oxidase is an
important upstream component of the chemoreception pathway (6, 15).
NADPH oxidase is a heteromultimeric enzyme that contains, importantly,
a PKC-activable subunit, p47phox (16). Fig. 7 shows, for
the first time, that mRNA for this subunit is present in H-146
cells. This observation has allowed us to exploit both PKC-regulation
of NADPH oxidase and the fact that the candidate K+ channel
is not selectively regulated by PKC per se (21) to test the
hypothesis that O2 transduction relies, at least in part, on the sensing of pO2 by NADPH oxidase. Clearly,
there are many targets for PKC-dependent phosphorylation.
However, there is accumulating evidence in NEB and NEB-derived cells
that, in terms of O2 signal transduction, NADPH oxidase
activity, and its regulation by PKC, are of paramount importance.
First, H2O2, a product of the sequential actions of NADPH oxidase and catalase/superoxide dismutase, appears to
provide the required oxidized environment needed for tonic K+ channel activity in normoxia (15); Fig. 2 shows clearly
that production of H2O2 by H-146 cells is
suppressed during hypoxia with a time course similar to that of hypoxic
K+ current inhibition (13). Second, phorbol 12-myristate
13-acetate treatment (another PKC-stimulating phorbol ester) causes a
dramatic increase in intracellular H2O2
concentration; presumably via activation of p47phox (15).
Based upon these observations, we would predict that any agent that
increases the affinity of NADPH oxidase for substrate will ameliorate
the inhibitory action of hypoxia.
To investigate the potential involvement of PKC in O2
sensing by H-146 cells, it was important first to characterize more completely the O2 sensitivity of hypoxic inhibition of
K+ currents in these cells. Fig. 1A shows that
the inhibition of K+ currents (measured at a test potential
of 0 mV) by hypoxia was clearly graded, with significant inhibition
only observed at a pO2 of 45 mm Hg or lower.
This is in accordance with studies of the
[Ca2+]i response of arterial
chemoreceptor cells (20) and further validates our own model system of
airway chemoreceptor cells. Most importantly, we found an excellent
correlation between hypoxia-induced K+ current suppression
and hypoxia-evoked membrane depolarization (Fig. 1B). This
finding justifies our use of measuring current amplitude at 0 mV (which
provides an acceptable compromise between signal to noise ratio and
resolution of the physiological action of hypoxia) as a reliable
indicator of events occurring at resting membrane potential, as we have
earlier suggested (14).
Phorbol ester activation of PKC often requires several minutes to
become maximal, and so to investigate the effects of PKC activation on
K+ currents in H-146 cells, we pretreated cells for 10 min
with such agents. Nonspecific inhibitory effects of phorbol esters on
ion channels have been documented previously (22), and the data shown
in Fig. 3 agree with this finding; phorbol ester treatment suppressed
mean current amplitude but this can be divided into both
PKC-dependent and -independent components. Because the
effects of TPA were partially reversed by inhibiting PKC with BIM, it appears that the PKC-dependent component is significant.
However, 4 Indeed, the most important observation of the present study is that TPA
modulates the O2 sensitivity of K+ currents in
H-146 cells (Figs. 4 and 5), and such a finding has important
implications for the frequently proposed involvement of NADPH oxidase
in O2 chemoreception in various tissues, including airway
chemoreceptors (15), arterial chemoreceptors (28), and pulmonary
vascular smooth muscle (29). This model proposes that O2
sensing is dependent on the generation of H2O2
by NADPH oxidase under normoxic conditions. This enzyme has been shown to produce H2O2 tonically, and both native and
recombinant subtypes of K+ channels (including those found
in NEB cells and SCLC cells (15)) have been shown to be enhanced by
H2O2, raising the attractive concept that
hypoxia inhibits K+ currents by reducing
H2O2 production by NADPH oxidase simply by
limiting the enzyme's substrate, O2. We have now provided
direct evidence that acute hypoxia reduces H2O2
production (Fig. 2). The ability of NADPH oxidase to generate
H2O2 can be enhanced by the phorbol ester
phorbol 12-myristate 13-acetate, which is another known activator of
PKC. Our findings indicate that the PKC-activating phorbol ester, TPA,
suppressed the ability of hypoxia to inhibit K+ currents in
H-146 cells. This specific action of TPA can be attributed to PKC
activation, because it was not mimicked by another phorbol ester,
4 In summary, PKC activation reduces the sensitivity of H-146 cells to
changes in pO2. Furthermore, because the
addition of H2O2, a downstream product of NADPH
oxidase, only activates K+ currents during hypoxia (when
H2O2 production is suppressed), it appears
likely that PKC-dependent phosphorylation modulates the
affinity of NADPH oxidase for O2, and the PKC substrate
p47phox (a component of the functional NADPH oxidase) is
clearly present in these cells. Taken together, these data show that
PKC is an important regulator of the O2-transduction
pathway and provide functional evidence that suggests that NADPH
oxidase is a major airway O2 sensor.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: School of
Biomedical Sciences, Worsley Medical and Dental Bldg., University of Leeds, Leeds LS2 9JT, UK. Tel.: 44 113 233 4236; Fax: 44 113 233 4228;
E-mail: p.z.kemp@leeds.ac.uk.
The abbreviations used are:
NEB, neuroepithelial
body;
SCLC, small cell lung carcinoma;
4-AP, 4-aminopyridine;
PKC, protein kinase C;
TPA, 12-O-tetradecanoyl;
4
O2 Sensing by Airway Chemoreceptor-derived Cells
PROTEIN KINASE C ACTIVATION REVEALS FUNCTIONAL EVIDENCE FOR
INVOLVEMENT OF NADPH OXIDASE*
§,
,
¶
School of Biomedical Sciences and the
§ Institute for Cardiovascular Research, University of
Leeds, Leeds LS2 9JT, United Kingdom
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-phorbol 12,13-didecanoate and TPA in
the presence of bisindolylmaleimide were also able to depress
K+ currents, only TPA could significantly ameliorate
hypoxic depression of these currents. Thus, protein kinase C (PKC)
activation modulates the sensitivity of these cells to changes in
pO2. Furthermore, because the addition of
H2O2, a downstream product of NADPH oxidase, could only activate K+ currents during hypoxia (when
endogenous H2O2 production is suppressed), it
appears likely that PKC modulates the affinity of NADPH oxidase for
O2 potentially via phosphorylation of the
p47phox subunit, which is present in these cells. These
data show that PKC is an important regulator of the
O2-transduction pathway and suggests that NADPH oxidase
represents a significant component of the airway O2 sensor.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-phorbol
12, 13-didecanoate (4
-PDD) and in some cases with the PKC inhibitor,
bisindolylmaleimide (BIM, 1 µM), for 10 min at room
temperature. Where used, 1 µM BIM was also included in
the pipette solution.
1.
Graded hypoxia was achieved by splicing variable lengths of gas-permeant tubing into the perfusion lines.
pO2 was measured (at the cell) using a polarized
(
800 mV), calibrated carbon fiber electrode (16); for the experiments
reported herein, the pO2 values were 150 (normoxia), 85, 45, 25, and 15 (hypoxia) mm Hg.
(when filled with
K+-rich pipette solution).
70 mV,
100 to +60 mV, ramp duration = 1 s, frequency = 0.1 Hz; (b) time series: holding potential =
70 mV,
single increment to 0 mV, step duration = 50 ms, frequency = 0.1 Hz.
-PDD treated cells, 4.7 ± 0.21 picoFarad (n = 23); TPA- and BIM-treated cells,
5.7 ± 0.50 picoFarad (n = 16). Statistical
comparisons were made using the paired or unpaired Student's
t test, as appropriate, with p < 0.05 being
considered significant.
1 RNA; Promega,
Southampton, Hampshire, UK) to remove genomic DNA contamination, before
re-extraction using the RNeasy Micro Kit. The remaining 50% was kept
in an untreated (uncleaned) state. The yield, purity, and integrity of
the RNA was verified by spectrophotometry at 260/280 nm, followed by
electrophoresis on 1% agarose, and was then stored in aqueous solution
at
80 °C. RT was performed on 1-µg aliquots of both cleaned and
uncleaned RNA using the reverse transcription system A3500 (Promega),
comprising Avian Myeloblastosis Virus reverse transcriptase and
oligo(dT) (15) primers (42 °C, 15 min). The resulting cDNA was
amplified by PCR and screened for p47phox RNA expression
using oligonucleotide primers (22-mers) designed against the published
sequence of human neutrophil cytosolic factor 1 (GenBankTM
accession number M55067 (18)). These primers (upstream: 5'-atgcaggtgagccatacgtcgc-3', downstream: 5'-tctttcctgatgacccaccagc-3') were chosen because they were predicted to amplify a region within a
single exon. Therefore, products from both reverse transcribed mRNA
and genomic DNA (the positive control used in this study) would be of
identical length. PCR reactions using the cleaned and uncleaned (as
positive control) cDNA were run in parallel. Amplification of
1-µl cDNA (equivalent to 160 ng of reverse-transcribed RNA) was
performed using a Hybaid (Ashford, Middlesex, UK) express thermal
cycler, in a volume of 50 µl, containing 2.5 units of Taq
DNA polymerase (Promega), under optimized conditions with 2.0 mM MgCl2: hot start = 94 °C/1 min;
denaturing = 94 °C/1 min, annealing = 64 °C/1 min,
extension = 72 °C/1 min for 30 cycles followed by a final
cycle, which had a 5-min extension. Products were separated on 2%
agarose gels and visualized with ethidium bromide/UV transillumination.
Because signal was relatively low from cleaned cDNA, a "turbo"
PCR was performed on 5 µl of the primary PCR products. Turbo PCR
conditions were identical to primary PCR. Sequencing was carried out by
dye terminator PCR with an ABI PRISM automated sequencer (School of
Biology, University of Leeds, UK).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
38.4 ± 3.8 mV
(p < 0.05, n = 7), a reduction of 9.5 mV. These values are similar to our previously published data (13).
Fig. 1B shows a plot of the mean current amplitude
versus membrane potential at the five grades of hypoxia
examined. Hypoxic reduction in whole cell K+ current
correlates well with membrane potential (r = 0.96) and strongly suggests, therefore, that the O2-sensitive current
contributes to the resting membrane potential in this airway
chemoreceptor cell model.

View larger version (17K):
[in a new window]
Fig. 1.
The response of H-146 cells to graded
hypoxia. A, mean outward K+ currents
(left axis, open circles) and membrane potentials
(right axis, closed circles) recorded during
graded depression in pO2 from 150 to 15 mm Hg.
Currents were recorded during 50-ms step depolarizations from a holding
potential of
70-0 mV; n
7 cells. Membrane
potential was measured in current clamp with I = 0 pA;
n
7 cells. B, mean current amplitude
versus mean membrane potential at the five separate
pO2 values. r = 0.96;
n
7.

View larger version (32K):
[in a new window]
Fig. 2.
Fluorescence measurement of
H2O2 production. A,
normalized mean rate of change of H2DCFDA fluorescence (± S.E.) during normoxic conditions (n = 6). B,
normalized mean rate of change of H2DCFDA fluorescence (± S.E.) before, during, and after perfusion of cells with hypoxic
(15 mm Hg) bath solution (n = 9). The period
of hypoxia is indicated by the horizontal bar.
For both A and B, the rate of fluorescence change
was calculated as described under "Data Handling and Calculations"
from raw data exemplified in the two insets.
-PDD (100 nM); and (b) TPA together with the PKC inhibitor, BIM (1 µM bath and pipette).
These maneuvers resulted in smaller, nonsignificant (p > 0.29, n = 5; p > 0.52, n = 10, respectively) reductions in currents (Fig. 3,
C-E), than were seen with TPA. This suggests that the
inhibition caused by TPA was attributable to both nonspecific actions
of phorbol esters and activation of PKC.

View larger version (27K):
[in a new window]
Fig. 3.
The effects of phorbol esters in normoxic
conditions. A-D, mean current-voltage relationships (± S.E.; dotted lines) recorded using the ramp protocol in
normoxia after no pretreatment (A, n = 11),
10-min pretreatment with 100 nM TPA (B,
n = 8), 100 nM 4
-PDD (C,
n = 5), and 100 nM TPA in the presence of 1 µM BIM (D, n = 10).
E, mean current amplitudes recorded in normoxia at 0 mV with
no bath additions (Control) and following pretreatment with
the agents shown beneath each bar. Number of observations in each
condition is as stated in A-D.
-PDD
(p = 0.18, n = 4) nor TPA in the
presence of BIM (p = 0.87, n = 5) could
significantly suppress the level of hypoxic inhibition of currents.

View larger version (28K):
[in a new window]
Fig. 4.
The effects of phorbol esters on hypoxic
depression of K+ currents. A and B,
exemplar I-V relationships during normoxia and two grades of hypoxia
(45 and 15 mm Hg) in untreated (A) and TPA-pretreated
(B) cells. Currents were recorded during 1-s ramp
depolarizations from a holding potential of 0 mV. C, mean
outward K+ current recorded from TPA-treated cells during
graded depression in pO2 from 150 to 15 mm Hg.
Currents were recorded at 0 mV during 1-s ramp depolarizations from a
holding potential of
70 to 60 mV, n = 4 cells.
D, mean current amplitudes recorded in hypoxia (15 mm Hg) at
0 mV with no bath additions (Control) and following
pretreatment with the agents shown beneath each bar. Number of
observations in each condition is as stated under "Results."

View larger version (28K):
[in a new window]
Fig. 5.
Effect of PKC activation on hypoxic
depression of 4-AP-insensitive K+
currents. A and B, exemplar
currents under control conditions and then before (4-AP),
during (4-AP + Hypoxia), and after (4-AP + Recovery) hypoxia (15 mm Hg) in the presence of 10 mM
4-AP. Traces were recorded from untreated (A) and
TPA-pretreated (B) cells. Currents were recorded during
50-ms step depolarizations from a holding potential of
70 to 0 mV.
C, mean time series plots of current amplitudes (with
vertical S.E. bars, averaged for eight control cells
(open circles) and eight TPA-treated cells (closed
circles)) evoked by repeated step depolarizations from
70 to 0 mV (50-ms duration, 0.2 Hz). 4-AP and hypoxia were applied for the
periods indicted by the horizontal bars. n = 8 cells in both conditions. D and E, bar graphs
(with vertical S.E. bars) showing effect of TPA treatment on
proportion of current inhibited by 10 mM 4-AP
(D) and proportion of 4-AP-resistant current, which is
inhibited by hypoxia (E, 15 mm Hg). Adapted from the
same data as shown in C.

View larger version (25K):
[in a new window]
Fig. 6.
Effect of H2O2
on 4-AP-insensitive K+
current. A, typical currents evoked from an example cell
before (Normoxia), during (Normoxia + H2O2), and after (Normoxia)
bath application of 2 mM H2O2.
B, typical currents evoked from a representative cell before
(Normoxia) and during hypoxia (Hypoxia) and
during continued exposure to hypoxia but in the additional presence of
2 mM H2O2 (Hypoxia + H2O2). Currents were evoked by step
depolarizations from
70 to 0 mV, and scale bars apply to both
A and B. 10 mM 4-AP was present
throughout in both cases. C, mean time series plot of
currents evoked from five cells as in A but normalized to
the first five currents evoked after the effects of 10 mM
4-AP had stabilized. H2O2 was applied for the
period indicated by the horizontal bar. D, as C,
except cells (n = 7) were exposed to hypoxia before and
during H2O2 application, as indicated by
horizontal bars.

View larger version (35K):
[in a new window]
Fig. 7.
RT-PCR of H-146 cell RNA employing
p47phox primers. A, 2% agarose
gel of PCR reaction products. Lane 1, water control.
Lanes 2 and 3, cDNA reverse transcribed from
cleaned RNA following primary (lane 2) and turbo (lane
3) PCR. Lanes 4 and 5, cDNA
reverse-transcribed from uncleaned RNA following primary (lane
4) and turbo (lane 5) PCR. Lane 6, DNA
ladder with marker sizes as indicated. 10 µl of reaction product was
loaded in each lane, and DNA was visualized using ethidium bromide.
B, the aligned sequences of p47phox and the PCR
product from cleaned cDNA show 99.2% identity.
Underlined sequences show the primer sites that were
employed for the PCR reaction in A.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-PDD, a phorbol ester that is inactive with respect to PKC
activation, also caused some current depression. Although these data
contrast with recent studies in type I carotid body cells, which
indicate that TPA selectively inhibits O2-sensitive
Ca2+-dependent K+ channels solely
via PKC activation (23), the O2-sensitive K+
current in H-146 cells is clearly not
Ca2+-dependent (13). Indeed, our most recent
study (14) has shown that the O2-sensitive K+
current in H-146 cells is likely to be a member of the recently characterized tandem-P domain family of K+ channels (TWIK
(24), TREK (25) TASK-1 (21), TASK-2 (26), and TRAAK (27)) and shows
structural similarities to TASK. Furthermore, our data in Fig.
5D show very clearly that proportionally the 4-AP-insensitive current (of which the O2-sensitive current
is a large component) is unaffected by phorbol ester treatment.
Therefore, although TPA causes a generalized depression of
K+ currents, it does not affect the
O2-sensitive component per se, but, instead, it
specifically ameliorates the hypoxia sensitivity of that component.
-PDD (which does not activate PKC) and was prevented by the PKC
inhibitor, BIM. Because the nonspecific suppressing effects of TPA on
K+ currents measured under normoxic conditions were largely
because of a PKC-independent action of TPA (see above), the
PKC-dependent suppression of hypoxic inhibition is likely
to occur at a site upstream of the channel itself. Furthermore, the
channel which is likely to underlie the hypoxia-sensitive
K+ current in H-146 cells is possibly TASK-related, and
TASK is insensitive to the actions of phorbol esters (21). The
cytosolic protein p47phox is one of several subunits
comprising the NADPH oxidase complex and is a known substrate for PKC
(16). Its stimulation by phorbol 12-myristate 13-acetate (presumed to
be mediated by PKC phosphorylation) has been suggested to account for
the enhanced H2O2 production under normoxic
conditions in NEB cells, as determined by rhodamine 123 fluorescence
(15). In the context of this finding, our results provide compelling
evidence that supports the idea that NADPH oxidase is the
O2 sensor in the hypoxic signal transduction pathway. In
this model, the tonic generation of H2O2 in
H-146 cells provides the appropriate environment for normoxic channel
activity. That this activity is maximal in normoxia is evidenced by the
ability of exogenously applied H2O2 to enhance
the O2-sensitive current amplitude only during hypoxia
(Fig. 6B) and not during normoxia (Fig. 6A). This
is in contrast to results reported for native NEB cells where
H2O2 transiently activates K+
currents in normoxia (15). This may be because of differences between
NEB and H-146 cell NADPH oxidase turnover or specific class of
K+ channel targeted. Although this may suggest limitations
of our model, it does not change the picture of the basic transduction pathway per se. Thus, following PKC activation,
H2O2 levels are likely to be enhanced in H-146
cells as they are in NEB cells (15) due possibly to increased affinity
of NADPH oxidase for O2. Evidence for a
PKC-dependent increase in substrate affinity is shown by
the kinetic analyses of depression of K+ currents during
graded hypoxia. These analyses, which are summarized in Fig.
8, show that PKC increases O2
affinity ~6-fold and provide an explanation for how
H2O2, and therefore, channel open state probability is maintained in the face of reduced
pO2.

View larger version (20K):
[in a new window]
Fig. 8.
Kinetic analyses of hypoxic inhibition of
K+ currents. The main figure shows
data from Figs. 1A and 3C normalized and fitted
to the Michaelis-Menton equation by iterative fitting using the method
of least squares. Open circles, control cells; filled
circles, TPA-pretreated cells. The inset shows the same
data transformed as a double reciprocal plot as described by the axes.
Both analyses predict that preincubation of cells with TPA decreases
the calculated Km of the system for O2
approximately 6-fold.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
-PDD, 4
-phorbol 12,13-didecanoate;
BIM, bisindolylmaleimide;
H2DCFDA, 2',7'-dichlorodihydrofluorescein diacetate;
pO2, partial pressure of oxygen (mm Hg);
RT, reverse transcription;
PCR, polymerase chain reaction.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Peers, C.
(1997)
Trends Pharmacol. Sci.
18,
405-408[Medline]
[Order article via Infotrieve]
2.
Gonzalez, C.,
Almarez, L.,
Obeso, A.,
and Rigual, R.
(1994)
Physiol. Rev.
74,
829-898 3.
Weir, E. K.,
and Archer, S. L.
(1995)
FASEB J.
9,
183-189[Abstract]
4.
Franco-Obregon, A.,
Urena, J.,
and Lopez-Barneo, J.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4715-4719 5.
Lopez-Barneo, J.,
Pardal, R.,
Montoro, R. J.,
Smani, T.,
Garcia-Hirschfeld, J.,
and Urena, J.
(1999)
Respir. Physiol.
115,
215-227[CrossRef][Medline]
[Order article via Infotrieve]
6.
Cutz, E.,
and Jackson, A.
(1999)
Respir. Physiol.
115,
201-214[CrossRef][Medline]
[Order article via Infotrieve]
7.
Youngson, C.,
Nurse, C.,
Yeger, H.,
and Cutz, E.
(1993)
Nature
365,
153-155[CrossRef][Medline]
[Order article via Infotrieve]
8.
Lauweryns, J. M.,
and Cokeleare, M.
(1973)
Z. Zellforsch. Mikrosk. Anat.
145,
521-540[CrossRef][Medline]
[Order article via Infotrieve]
9.
Leach, R. M.,
Twort, C. H. C.,
Cameron, I. R.,
and Ward, J. P. T.
(1992)
Clin. Sci. (Lond.)
82,
55-62[Medline]
[Order article via Infotrieve]
10.
Fu, X. W.,
Nurse, C.,
Wang, Y. T.,
and Cutz, E.
(1999)
J. Physiol. (Lond.)
514,
139-150 11.
Gazdar, A. F.,
Helman, L. J.,
Israel, M. A.,
Russell, E. K.,
Linnoila, R. I.,
Mulshine, J. L.,
Schuller, H. M.,
and Park, J. G.
(1988)
Cancer Res.
48,
4078-4082 12.
Pancrazio, J. J.,
Viglione, M. P.,
Tabbara, I. A.,
and Kim, Y. I.
(1989)
Cancer Res.
49,
5901-5906 13.
O'Kelly, I.,
Peers, C.,
and Kemp, P. J.
(1998)
Am. J. Physiol.
275,
L709-L716 14.
O'Kelly, I.,
Stephens, R. H.,
Peers, C.,
and Kemp, P. J.
(1999)
Am. J. Physiol.
276,
L96-L104
15.
Wang, D.,
Youngson, C.,
Wong, V.,
Yeger, H.,
Dinauer, M. C.,
Vega- Saenz de Miera, E.,
Rudy, B.,
and Cutz, E.
(1996)
Proc. Natl. Acad. Sci., U. S. A.
93,
13182-13187 16.
Tardif, M.,
Rabiet, M. J.,
Christophe, T.,
Milcent, M. D.,
and Boulay, F.
(1998)
J. Immunol.
161,
6885-6895 17.
Reynolds, I. J.,
and Hastings, T. G.
(1995)
J. Neurosci.
15,
3318-3327[Abstract]
18.
Rodaway, A. R.,
Teahan, G. C.,
Casimir, C. M.,
Segal, A. W.,
and Bentley, D. L.
(1990)
Mol. Cell. Biol.
10,
5388-5396 19.
Lopez-Barneo, J.
(1996)
Trends Neurosci.
19,
435-440[Medline]
[Order article via Infotrieve]
20.
Buckler, K. J.,
and Vaughan-Jones, R. D.
(1994)
J. Physiol. (Lond.)
476,
423-428 21.
Duprat, F.,
Lesage, F.,
Fink, M.,
Reyes, R.,
Heurteaux, C.,
and Lazdunski, M.
(1997)
EMBO J.
16,
5464-5471[CrossRef][Medline]
[Order article via Infotrieve]
22.
Hockberger, P., Toselli, M., Swandulla, D., and Lux, H. D. (198)
Nature 338, 340-342
23.
Peers, C.,
and Carpenter, E.
(1998)
J. Physiol (Lond.)
512,
743-750 24.
Lesage, F.,
Guillemare, E.,
Fink, M.,
Duprat, F.,
Lazdunski, M.,
Romey, G.,
and Barhanin, J.
(1996)
EMBO J.
15,
1004-1011[Medline]
[Order article via Infotrieve]
25.
Fink, M.,
Duprat, F.,
Lesage, F.,
Reyes, R.,
Romey, G.,
Heurteaux, C.,
and Lazdunski, M.
(1996)
EMBO J.
15,
6854-6862[Medline]
[Order article via Infotrieve]
26.
Reyes, R.,
Duprat, F.,
Lesage, F.,
Fink, M.,
Salinas, M.,
Farman, N.,
and Lazdunski, M.
(1998)
J. Biol. Chem.
273,
30863-30869 27.
Fink, M.,
Lesage, F.,
Duprat, F.,
Heurteaux, C.,
Reyes, R.,
Fosset, M.,
and Lazdunski, M.
(1998)
EMBO J.
17,
3297-3308[CrossRef][Medline]
[Order article via Infotrieve]
28.
Cross, A. R.,
Herderson, L.,
Jones, O. T. G.,
Delpiano, M. A.,
Hentschel, J.,
and Acker, H.
(1990)
Biochem. J.
272,
743-747[Medline]
[Order article via Infotrieve]
29.
Marshall, C.,
Marary, A. J.,
Verhoeven AJ,
and Marshall, B. E.
(1996)
Am. J. Respir. Cell Mol. Biol.
15,
633-644[Abstract]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. K. Weir and S. L. Archer COUNTERPOINT: HYPOXIC PULMONARY VASOCONSTRICTION IS NOT MEDIATED BY INCREASED PRODUCTION OF REACTIVE OXYGEN SPECIES J Appl Physiol, September 1, 2006; 101(3): 995 - 998. [Full Text] [PDF] |
||||
![]() |
D. Adriaensen, I. Brouns, I. Pintelon, I. De Proost, and J.-P. Timmermans Evidence for a role of neuroepithelial bodies as complex airway sensors: comparison with smooth muscle-associated airway receptors J Appl Physiol, September 1, 2006; 101(3): 960 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kemp Detecting acute changes in oxygen: will the real sensor please stand up? Exp Physiol, September 1, 2006; 91(5): 829 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. He, B. Dinger, K. Sanders, J. Hoidal, A. Obeso, L. Stensaas, S. Fidone, and C. Gonzalez Effect of p47phox gene deletion on ROS production and oxygen sensing in mouse carotid body chemoreceptor cells Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L916 - L924. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Weir, J. Lopez-Barneo, K. J. Buckler, and S. L. Archer Acute Oxygen-Sensing Mechanisms. N. Engl. J. Med., November 10, 2005; 353(19): 2042 - 2055. [Full Text] [PDF] |
||||
![]() |
J. M. V. Mammen, J. C. Song, J. Yoo, P. S. Kim, H. W. Davis, M. I. Calvo, R. T. Worrell, K. S. Matlin, and J. B. Matthews Differential subcellular targeting of PKC-{epsilon} in response to pharmacological or ischemic stimuli in intestinal epithelia Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G135 - G142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Acker and H. Acker Cellular oxygen sensing need in CNS function: physiological and pathological implications J. Exp. Biol., August 15, 2004; 207(18): 3171 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Michiels Physiological and Pathological Responses to Hypoxia Am. J. Pathol., June 1, 2004; 164(6): 1875 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Miller, C. Peers, and P. J. Kemp Polymodal |